Summary. The study was aimed at testing the hypothesis that sulfonylureas do not readily penetrate the pancreatic E-cells but more probably stimulate insulin release by a direct action on the #-cell plasma membrane. Uptake of radioactively labelled tolbutamide and glibenclamide by microdissected pancreatic islets of obesehyperglycemic mice was compared with the uptake of 3-0-methyl-D-glucose, to which the #-cells are permeable. In contrast to tolbutamide, glibenclamide was taken up in amounts exceeding the 3-O-methyl-D-glucose space of islets incubated in the absence of serum albumin. Uptake of the sulfonylureas was easily reversible. It was depressed by serum albumin, whereas glucose, leucine or diazoxide had no effects. Antimycin A, p-chloromercuriphenylsulfonie acid and chlorpromazine, all of which increase the uptake of extracellular space markers, strongly stimulated the islet uptake of tolbutamide and glibenclamide but had no effect on the uptake of glibenelamide by subcellular particles of homogenized islets. The results suggest that sulfonylureas bind reversibly to islet tissue but are normally restricted to the outside of the/~-eells.
Sulfonylurea compounds are widely used in the treatment of diabetes mellitus. These drugs may have direct effects on several tissues, but it is generally assumed that their therapeutic value is mainly due to stimulation of insulin release (Loubati6res, 1968; Grodsky, 1971) . The sensitivity of the pancreatic flcells to sulfonylureas is poorly understood. It seems reasonable to expect that insight into their mode of action would promote the understanding of physiological insulin release as well. In a previous communication we reported that microdissected pancreatic islets have a tolbutamide space which is equal to their sucrose and mannitol spaces and significantly smaller than their 3-O-methyl-D-glucose space (Hellman et al., 1971a) . These observations indicated that tolbutamide does not readily penetrate into fi-cells. Consequently it was suggested that the fl-eell plasma membrane contains a tolbutamide receptor, which is responsible for the recognition of sulfonylureas as insulin seeretagogues. These results are probably representative of the in rive situation, since the incubations were performed with albumin present in the media. The fact that sulfonylureas have a great affinity for albumin (Judis, 1972) makes it also interesting to study the effect of albumin on the islet uptake of sulfonylureas. This seems particularly important in view of conflicting reports that the fl-cells may be permeable to glibenelamide (Howell and Lacy, 1969) , another sulfonylurea with pronounced insulin-releasing ability. In the present paper we report data on the uptake of glibenclamide and tolbutamide by microdisseeted islets from obese-hyperglycemic mice. The effects of albumin and other compounds on the uptake of these drugs have been studied with particular reference to the question whether or not sulfonylureas readily enter the pancreatic/?-cells.
Materials and Methods
Chemicals. 1-Butyl-3-[p-tolyl-(85S)sulfonylJurea (tolbutamide) and 3-O-methyl-D-(1-3H)glucose were obtained from the Radiochemical Centre, Amersham, England. N-4-[2-(5-chloro-2-methoxy-benzamido)-ethyl]-phenyl-sulfonyl-N'-eyclohexyl-Q~C)urea (glibenclamide) as well as non-radioactive glibenelamide were donated by Farbwerke t-Ioechst, Frankfurt/M, Germany. 7-Chloro-3-methyl-1,2,4-benzothiadiazine-1,1-dioxide (diazoxide) was a gift from Schering Corp., Bloomfield, N.J., U.S.A. p-Chloromercuriphenylsulfonic acid (PCMBS) and antimycin A were from Sigma Chemical, Co., St. Louis, Me., U.S.A., and chlorpromazine chloride from AB Leo, Helsingborg, Sweden. Human serum albumin (grade A, less than 2% other proteins) was from Kabi AB, Stockholm, Sweden.
Preparation of islets. Adult male obese-hyperglycemic mice (gene symbol: ob/ob) from the Umes colony were starved overnight. Fresh pancreatic islets were isolated by free hand microdissection (I-IellerstrSm, 1964) in gassed (03 + COs, 95 : 5) Krebs-Ringer bicarbonate buffer (Umbreit et al., 1964) . No collagenase was used in the isolation procedure.
Incubations. All incubations were performed at 37 ~ C, using Krebs-Ringer bicarbonate buffer equilibrated with O2~-CO 2 (95:5) as the basal medium. Additions to the media are described in the legends to figures and tables. Uptake of radioactively labelled sulfonylureas by incubated islets was studied in relation to the simultaneous uptake of 3-O-methyl-D-(1-att)glucose, to which the fl-cells are permeable (tIellman et al., 1971 b) . This design made it possible to estimate the cellular uptake of sulfonylureas without washing the islets after incubation. In view of the pharmacological potency of glibenclamide, it was of interest to study the islet uptake of this drug at concentrations as low as 10 ~M. To reduce the risk of an interference between the drug and the space marker, 3-O-methyl-D-glucose was used at a concentration of only 1.3 ~M in these experiments. This concentration is several orders of magnitude lower than those previously used (Hellman et al., 1971b) , which introduces a source of uncertainty as to the physical counterpart of the apparent 3-O-me~hyl-D-glucose space. A series of control experiments revealed, however, that islets incubated in a medium containing both 1.3 t~SI 3-O-methyl-D-(1-3H)-glucose and 0.5 mM (laC)urea had an apparent 3-0-methyl-D-glucose space that was not smMler than the urea space. Uptake of glibenelamide in excess of the 3-O.methyl-D-glucose space therefore means a greater uptake of the drug than would be expected as the result of passive distribution in the total tissue water.
One series of experiments was performed to study the uptake of glibenclamide by subeeltular islet particles. In each experiment 25 to 30 islets were homogenized in 75 ~I basal medium, using a mieroseMe pestle homogenizer made of perspex. After eentrifugation at about 400 g for 10 min, 10 ~l samples of the supernatant were assayed for protein (Lowry et al., 1951) or were incubated for 90 rain with 90 ~l medium containing glibenelamide, 3-O-methyl-Dglucose, and test substances as described in the legend to Table 2 . The mixtures of homogenate and medium were then filtered on membrane filters with a pore size of 0.5 micron (Oxoid Ltd., England). After drying, the filters were analyzed for sH and IaC.
Weighing of islets and counting of radioactivity. After incubation the islets were placed on pieces of aluminum foil and with the aid of a micropipette they were freed of as much contaminating fluid as possible. This procedure was standardized to take only a few seconds, after which the islets were plunged into isopentane cooled to its melting-point (--160 ~ C). The islets were then freeze-dried (--40~ 0.001 mm Hg) overnight and were weighed on a quartz-fiber balance. The weighed islets were dissolved in hyamine and analyzed for sH, 14C, and asS in a liquid scintillation spectrometer as previously described (Hellman et at., 1971a, b) .
Calculation of results. Results are expressed as mmol sulfonylurea taken up per unit dry weight of islets. In addition to the total uptake, data on the uptake in excess of the 3-O-methyl-D-glucose space will be given.
(mmol sulfonylurea in islet) --(concentration of sulfonylurea in medium) • (3-O-methyl-D-glucose space). This expression wilt be negative when the amount of sulfonylurea taken up is less than that which corresponds to a passive distribution of the drug in the 3-0-methyl-D-glucose space.
Results

Time-course of sulJbnylurea uptake and release
Fig . 1 shows the time course of islet uptake of sulfonylurea in the absence of serum Mbnmin. Tolbutamide did not exceed the 3-O-methyl-I)-gineose space, whereas glibenclamide accumulated to high levels. The uptake of glibenclamide was apparently a linear function of its concentration in the range l0 to 100 ~?r (Fig. 2 ). As shown in Fig. 3 , islets preloaded with radioactive glibenelamide rapidly lost their label upon transfer to a medium free from glibenelamide. Tolbutamide was even more rapidly washed out from islets preloaded with this drug (Fig. 3 ).
Effect of albumin on the uptake of sulfonylurea
The demonstration of a marked accumulation of glibenclamide in islets incubated in the absence of serum albumin does not mean that the drug is taken up in large amounts in rive as well. To test whether the presence of albumin would affect the uptake of this drug, islets were incubated for 60 rain with 20 ~M ~dC-labelled glibenelamide (52 mCi/mmot) and 1.3 ~M 3~ O-methyl-D-(1-aH)glueose (3 Ci/mmol) in basal medium containing or lacking 0.3% (w/v) serum albumin. The mean value~ S.E. (n= 8) for uptake of glibenclamide in excess of the 3~O-methyl-D-glucose space was 0.52 & 0.04 mmol/kg dry islet for incubations in albumin-free medium, and --0.06 4-0.003 mmol/kg dry islet for incubations in the presence of albumin. This effect of albumin was significant at the 0.1%-level. 
E. for 6 experiments
The effect of albumin on the islet uptake of glibenclamide is also demonstrated in Fig. 4 . When islets were preloaded and brought to equilibrium with ltClabelled glibenelamide in an albumin-free medium, the addition of serum albumin to the radioactive medium resulted in a rapid loss of 14C from the islets. The new equilibrium was apparently the same as that observed when islets were exposed to l~C-labelted glibenelamide and albumin throughout the whole incubation. 
Effect of collagenase on the uptake of glibenclamide
Islets microdissected free-hand are surrounded by a delicate connective-tissue capsule, whereas this capsule is lost in the preparation of isolated islets by collagenase digestion (Lernmark, 1971) . To test whether the presence of the capsule affects the uptake of sulfonylurea, we compared the uptake of glibenclamide in ordinarily microdissected islets with that in islets After preincubation for 30 min in basal medium supplemented with one of the listed test substances, islets were incubated for 60 rain with radioactive sulfonylurea as well as test substance as indicated. In each experiment parallel control incubations were also performed in the absence of test substance. The incubation media contained 20 ~M 14C-labelled glibenclamide (52 mCi/mmol) and 1. 
Effects of various compounds on the uptake of sulfonylurea
The insulin-releasing action of sulfonylureas can be potentiated by glucose or leucine (Grodsky, 1971 ) and counteracted by diazoxide (Loubatigres, 1968) . Table 1 shows that none of these substances had any significant effect on the islet uptake of tolbutamide and glibenclamide. However, the uptake of these drugs was greatly increased by 0.5 mM p-ehloromercuriphenylsulfonie acid (PCMBS), 10 `aM antimyein A or 0.5 mM chlorpromazine. Previous results had indicated that treatment with PCMBS for 1 h results in an increased permeability of the fl-eell plasma membrane to small organic solutes which are normally restricted to the extracellular space (Bloom et al., 1972) . To test whether antimycin A and ehlorpromazine have a similar effect, islets were incubated for 60 rain in albumin-free media containing 0.3 m~ (U-laC) sucrose (50 mCi/ Samples of islet homogenates were assayed for protein or were incubated for 90 min with basal medium containing 20 ~M l~C-labelled glibenelamide (52 mCi/mmol) and 1.3 ~lVi 3-O-methyl-D-(1-att)glucose (3 Ci/mmol). Control incubations were performed without further additives, whereas test incubations were carried out in media also containing 0.5 mM PCMBS, 10 tzlV[ antimycin A or 0.5 mM ehlorpromazine. The mixtures of homogenate and medium were then filtered and the retained particles analyzed for 3I-I and 1~C. After correction for label in the 3-O-methyl-D-glucose space, the amounts of particlebound glibenelamide were calculated per unit protein of the incubated homogenate. Results are given as mean values ~ S.E. for test incubations as well as for the differences between paired test and control incubations. ap < 0.05.
0.03 mmol sucrose/kg dry islet (mean value-~ S.E. for 6 experiments). Similarly, 0.5 mM ehlorpromazine caused an increase of the sucrose space corresponding to 0.56• mmol sucrose/kg islet (mean value:j: S.E. for 4 experiments; P<0.02). After incubation with this compound there was no difference between the sucrose and 3-O-methyl-D-glucose spaces.
The above results suggest that PCMBS, antimycin A and ehlorpromazine increased the islet uptake of tolbutamide and glibenclamide by increasing the fi-eell permeability to snlfonylnreas. If this interpretation is correct, PCMBS, antimycin A and chlorpromazine would not be expected to enhance the uptake of sulfonylureas by fragments of homogenized islets. To test this prediction, homogenized islets were incubated with ~4C-labelled glibenelamide, and the uptake by subcellular particles was measured after filtration on oxoid filters. Table 2 shows that PCMBS, antimycin A or ehlorpromazine did not stimulate the uptake of glibenelamide by the particles retained by the filters. On the contrary, PCMBS significantly inhibited the uptake of glibenclamide by subeellular particles, which suggests that part of the uptake may involve binding to thiol groups. It should be pointed out that the particles retained by oxoid filters are not representative of the whole islet homogenate, which probably explains the lower values obtained in this type of experiments as compared with the data of Table 1.
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Discussion
The concentrations of sulfonylnreas used in the present study were chosen with a view to the pharmacological potency of these drugs. Studies on the release of insulin from isolated rat islets showed that the threshold dose for stimulation with glibenelamide (1.2 ~M) was only 1/t00 of that required for stimulation with tolbutamide (Lhffler et al., 1969) . Although a similar and systematic comparison has not been performed with the kind of islets used here, graded responses of insulin release were observed with glibenelamide concentrations varying between 0.2 and 200 pa~ [ (I-Iellman et al., 1969) . The lowest intravenous dose capable of lowering the blood sugar in mice has been reported to be &00 times higher for tolbutamide than for glibenelamide (Bander et al., 1969) .
In discussing the present results, we shall assume that the degradation of sulfonyhireas was neglible in comparison with the amounts of these drugs that were taken up by the islets. There are no data available to prove the validity of this assumption. Control experiments revealed, however, that the radioactive carbon atom of glibenelanlide was not significantly lost by oxidation to 14CO~. This observation is in accordance with wevious reports that 8 h after administration of ~4C-labelled glibenelamide to rabbits, dogs, and rats, less than 1 ~o of the radioactivity, had been lost through respiration (Heptner et al., 1969) .
The molecular weight of ionized drugs is often too large to permit diffusion through the pores of plasma membranes (t{ogben, 1971 ). An exception may be observed in hepatoeytes, which permit the passage of ions with relatively high molecular weights. It is therefore not surprising that significant amounts of toIbutamide have been observed in bile (B/inder and Seholz, 1956) , whereas the drug was reported to be restricted to the ex~raeellular space in eviscerated and nephrectomized rabbits (%Vick et al., 1956) as well as in man (Stowers et al., 1958) . We have previously reported that pancreatic islets incubated in the presence of albumin did not take up more tolbutamide than was explicable in terms of a passive distribution of the compound in the extraeellular space (Hellman et al., 1971 a) . TMs result indicated that tolbutamide did not penetrate the B-cells, although it could not be ruled out that the drug entered in amounts below the detection limit of our technique. It was consequently suggested that sulfonylureas act on a receptor in the fl-ccll plasma membrane. The same arguments cannot be applied to the remflts obtained with glibenelamide, since in the absence of albumin the uptake of this drug was greater than what corresponded to the 3-O-methyl-D-glucose space. These observations are in agreement with those of Howell and Lacy (1969) , who reported that glibenelamide did not behave as an extracellular space marker in rat islets. From these data alone, no conclusion can be drawn concerning the ability of glibenelamide to penetrate the B-cells, since it is not known how much of the drug was bound to plasma membranes. However, some indirect information may be extracted from the observed effects of PCMBS, antimyein A and ehlorpromazine. These compounds increased the islet uptake of sucrose, which suggests that they make the fi-cells more permeable. Millimolar concentrations of chlorpromazine have previously been reported to exert a lyric effect on rat islet cells (Orei et al., 1972) . If the sulfonylureas are normally restricted to the outside of the fl-cells, an increased membrane permeability could well result in an increased uptake of the drugs. The stimulatory effects of PCMBS, antimyein A and ehlorpromazine on tile islet uptake of glibenelamide and tolbutamide are therefore in agreement with the hypothesis that under normal conditions the suffonylureas do not readily penetrate the B-cell plasma membrane. This interpretation is supported by the failure of PCMBS, antimyein A and ehlorpromazine to stimulate the uptake of glibenelamide by subeellular particles of disintegrated islets.
The time-curves for loss of label from islets preloaded with radioactive sulfonylureas indicate that most of the uptake is easily reversible. This is in line with the observation that the islet uptake of sulfonyL ureas was markedly reduced when albmnin was wesent in the incubation medium; it is welI known that sulfonylureas bind strongly to serum proteins (Judis, 1972) . The concentration of albumin used in the present study, 3 mg/ml, is not higher than that thought to be present in the interstitial tissue fluid and considerably lower than that in serum. Insofar as the islet uptake of sulfonylnreas is related to their hypoglyeemie action, our results ~re compatible with the idea that the therapeutic effect may be potentiated by compounds which are able to displace the drugs from. serum albumin (Judis, 1972) . The distribution of glibenclamide in the mouse has previously been studied with whole body autoradiography, Which did not reveal any concentration of the drug in the pancreatie islets as compared with blood (I-Iellman et al., 1969) . This result agrees well with the present observation that the glibenclamide space did not exceed that of 3-O-methyl-D-glucose in islets incubated in the presence of serum albumin.
In view of the non-specific affinity of sulfonylureas for proteins, the marked uptake of glibenelamide by islets incubated in albumin-free media should not necessarily be understood as specific binding to the hypothetical snl~onylurea receptor in the B-cells. Nevertheless, we may of course ask whether the much greater uptake of glibenclamide than of toIbutamide is related to the greater potency of glibenelamide as an insulin seeretagogue (Lhffler et al., t969) . Studying the perfused rat pancreas, Loubatigres (t968) observed a difference between tolbutamide and glibenelamide with regard to the "turla-off" kinetics of insulin release; the stimulatory action of glibenclamide persisted for a longer time after withdrawal of the drug. As pointed out by Grodsky (1968) , this difference does not prove that the fl-eells have a better "memory" for glibenclamide than for tolbutamide, since it was not known how rapidly the two drugs disappeared from the perfused pancreas. In the present study there was a slower washout of glibenclamide than of tolbutamide from islets preloaded with the sulfonylureas.
There are previous reports that sulfonylurcas affect glucose metabolism, oxygen consumption, and cyclic nucleotide phosphodiesterase activity in the pancreatic islets Stork et al., 1969 ; Montague and Taylor, 1969; Ashcroft et al., 1970; Ashcroft et al., 1972) . It has also been suggested that the insulin-releasing effect of sulfonylureas may be related to their ability to uncouple oxidative phosphorylation and alter the "phosphate potential" in the/?-cells (I-lellman et al., 1969; Ilellman, 1970) . The latter idea was an attempt to explain the action of sulfonylureas in a manner that would be theoretically economical in not requiring the assumption of regulatory mechanisms for insulin release other than glucose metabolism. Although subsequent studies have indicated that such attempts may be unduly monolithic (I-Iellman et al., 1971c) , further experiments appear necessary in order to assess the importance of the metabolic alterations observed in islets exposed to sulfonylureas. It should be pointed out that the hypothesis that these drugs act primarily on the/?-cell plasma membrane has no implications as to the number and nature of effects that may arise from binding to the hypothetical receptor. It seems possible that such binding could result in intracellular metabolic effects which are significant for, or consequences of, the stimulated insulin release.
